Koltsova Lab

Biomedical scientist working on inflammation, metabolism, microbiota, cardiovascular diseases and cancer, views are my own and do not represent my employer.

[Cancer Discovery @CD_AACR]

Interleukin-27 Signaling Serves as an Immunological Checkpoint for Innate Cytotoxic Cells to Promote #HepatocellularCarcinoma, by @TuranAghayev, @aleks_mazik, Jennifer Fang, @KatyaKoltsova et al.
https://t.co/4OPk9sHUSH
@CSCancerCare @CedarsSinai @FoxChaseCancer @theNCI

[Koltsova Lab @KatyaKoltsova]

@Zhang_Lab_UFL @CD_AACR thanks!

[Koltsova Lab @KatyaKoltsova]

Great time to start tweeting. Happy to share our paper “Interleukin-27 signaling serves as an immunological checkpoint for innate cytotoxic cells to promote hepatocellular carcinoma” finally published in Cancer Discovery @CD_AACR. 1/1 https://t.co/46imoHUWK9

[Elizabeth McKenna @ElizSMcKenna]

Now in @CD_AACR: Interleukin-27 Signaling Serves as an Immunological Checkpoint for Innate Cytotoxic Cells to Promote #HepatocellularCarcinoma @TuranAghayev @aleks_mazik Jennifer Fang @KatyaKoltsova et al @CSCancerCare @CedarsSinai @FoxChaseCancer @theNCI https://t.co/wSmBrQNVPw

[Denise Heady @dheady8]

A new @CSCancerCare study suggests targeting a newly identified immune checkpoint pathway could lead to a better understanding of hepatocellular carcinoma. @KatyaKoltsova https://t.co/LAKr9EAyN7

[Koltsova Lab @KatyaKoltsova]

We thank all our multiple collaborators for help with our work (@SGrivennikov and many others), and Reviewers and Editors at Cancer Discovery, especially @ElizSMcKenna for handling the manuscript. (end of the thread). 1/7

[Koltsova Lab @KatyaKoltsova]

We hope that this discovery of a novel IL-27-dependent mechanism controlling anti-cancer cytotoxic immune response will pave the road for new treatment options for HCC and look forward to further study mechanisms how IL-27R pathway operates in cancer 1/6

[Koltsova Lab @KatyaKoltsova]

Joining Twitter at last to tweet and learn about science in our lab and our field
@FoxChaseCancer